JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for OPUS GENETICS, INC · ophthalmic biotechnology company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate · $15,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Health Issues

issues related to FDA regulation of gene therapies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem